Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EPAM Systems Inc (EPAM) vs 10X Genomics Inc (TXG) Price & Performance

EPAM Systems IncTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

EPAM Systems Inc vs 10X Genomics Inc — how do they compare? EPAM Systems Inc trades at $99.5 (market cap $5.15B), while 10X Genomics Inc trades at $58.56 (market cap $7.61B). The key difference: 10X Genomics Inc is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, EPAM Systems Inc nearer its low. Which is the better fit depends on your goals.

EPAMTXG
Market Cap
$5.15B$7.61B
Sector
TechnologyHealth
52-Week High
$221.40$58.57
52-Week Low
$76.04$11.34
Enterprise Value
$4.52B$7.14B

Returns comparison

Trailing returns across standard periods

About EPAM Systems Inc

EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.

Read more on EPAM

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG